Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apararenone in Type 2 Diabetic Nephropathy
NCT01756703Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Nov 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of apararenone in diabetic nephropathy (DN), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Nov 2012; status: completed.
02
Drugs
apararenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01756703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756703.